Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
04 - 25 Oct 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Version / remarks:
adopted in 2001
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Version / remarks:
adopted in 2008
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
Version / remarks:
adopted 2002
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Schwabach, Germany
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
2-[(oxolan-2-yl)methoxy]ethan-1-ol
EC Number:
608-659-1
Cas Number:
31692-85-0
Molecular formula:
C5H10O2[C2H4O]n, n = 0, 1, 2, 3, 4, ... (data given for max n of 4)
IUPAC Name:
2-[(oxolan-2-yl)methoxy]ethan-1-ol

Test animals

Species:
rat
Strain:
Wistar
Remarks:
Crl: WI(Han)
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 8 - 10 weeks
- Weight at study initiation: step 1: 156 - 169 g; step 2: 164 - 178 g
- Fasting period before study: animals were fasted 16 - 19 h prior to administration
- Housing: group-caged in IVC cages, type III H, polysulphone cages on Altromin saw fibre bedding
- Diet: Altromin 1324 maintenance diet for rats and mice, ad libitum
- Water: tap water, sulphur acidified to a pH value of approx. 2.8, ad libitum (analysis were performed)
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 10
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
MAXIMUM DOSE VOLUME APPLIED: no information provided in the test report

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: no information provided in the test report
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
3 females per step (2 steps)
Control animals:
no
Remarks:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: On the day of dosing animals were observed for general clinical signs, morbidity and mortality at least once during the first 30 min and with more attention during the first 4 h, then once daily. Body weights were determined on Day 1 prior to dosing, on Day 8 and Day 15.
- Necropsy of survivors performed: yes
Statistics:
Mean values and standard deviations were calculated for body weights.

Results and discussion

Effect levelsopen allclose all
Sex:
female
Dose descriptor:
LD50 cut-off
Effect level:
5 000 mg/kg bw
Based on:
test mat.
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality occurred during the study period.
Clinical signs:
other: Slightly reduced spontaneous activity, moderate piloerection, hunched posture, slow movements, slight ataxia and prone position were observed in all 6 animals during the first 2 days, but vanished afterwards.
Gross pathology:
No abnormal morphological findings were observed in any animal.

Any other information on results incl. tables

Table 1: Absolute body weights and body weight gain

Step  Animal No. Starting dose (mg/kg bw) Body weight (g) Body weight gain in comparison to Day 1 (%)
Day 1 Day 8 Day 15
1 1 2000 168 184 199 18
2 156 185 192 23
3 169 197 207 22
2 4 173 191 196 13
5 164 181 196 20
6 178 206 220 24

Applicant's summary and conclusion

Interpretation of results:
other: CLP/ EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Conclusions:
An acute oral toxicity study according to OECD Guideline 423 in rats was performed with the test substance and resulted in a LD50 greater than 2000 mg/kg bw. Thus the test substance does not meet the classification criteria according to Regulation (EC) 1272/2008, and its data are therefore conclusive but not sufficient for classification.